Andrew H. Limper

20.5k citations

290 papers · 14.3k indexed · 4 hit papers · h-index 61

Epidemiology top 0.1%
Pulmonary and Respiratory Medicine top 0.2%
Infectious Diseases top 0.1%
Physiology top 1%
Molecular Biology top 5%

Co-authors: Charles F. Thomas Joseph E. Standing Thomas V. Colby Theodore J. Kottom Robert Vassallo Eva M. Carmona Steven H. Yale Edward B. Leof
Topics: Pneumocystis jirovecii pneumonia detection and treatment (153 papers)Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis (74 papers)Pneumonia and Respiratory Infections (62 papers)
Cited by: Infectious Diseases Epidemiology Pulmonary and Respiratory Medicine
Journals: New England Journal of Medicine Proceedings of the National Academy of Sciences Journal of Biological Chemistry
Partner nations: United States China United Kingdom

In The Last Decade

Andrew H. Limper

279 papers receiving 14.0k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Pneumocystis Pneumonia

2004 708 citations Andrew H. Limper et al. profile →
Transforming growth factor beta 1 is present at sites of extracellular matrix gene expression in human pulmonary fibrosis.

1991 690 citations Andrew H. Limper, Thomas V. Colby et al. profile →
Fungal infections in HIV/AIDS

2017 322 citations Andrew H. Limper et al. profile →
Senolytics dasatinib and quercetin in idiopathic pulmonary fibrosis: results of a phase I, single-blind, single-center, randomized, placebo-controlled pilot trial on feasibility and tolerability

2023 140 citations Nathan K. LeBrasseur, Andrew H. Limper et al. profile →

Peers

Countries citing papers authored by Andrew H. Limper

Since Specialization

Citations

This map shows the geographic impact of Andrew H. Limper's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Andrew H. Limper with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Andrew H. Limper more than expected).

Fields of papers citing papers by Andrew H. Limper

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Andrew H. Limper. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Andrew H. Limper. The network helps show where Andrew H. Limper may publish in the future.

Co-authorship network of co-authors of Andrew H. Limper

This figure shows the co-authorship network connecting the top 25 collaborators of Andrew H. Limper. A scholar is included among the top collaborators of Andrew H. Limper based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Andrew H. Limper. Andrew H. Limper is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	An Observational Analysis of a Large Cohort of Pneumocystis jirovecii Pneumonia 2025 ·Open Forum Infectious Diseases ·(unknown),Holenarasipur R. Vikram,Michael B. Gotway,Rodrigo Cartin‐Ceba,Henry Ma,Andrew S. Johnson,(unknown),(unknown),(unknown),(unknown),Andrew H. Limper,Ayan Sen,Augustine S. Lee,Kealy R. Ham	1
2	Treatment of Invasive Pulmonary Aspergillosis and Preventive and Empirical Therapy for Invasive Candidiasis in Adult Pulmonary and Critical Care Patients: An Official American Thoracic Society Clinical Practice Guideline 2024 ·American Journal of Respiratory and Critical Care Medicine ·Oleg Epelbaum,Tina Marinelli,Qusay Haydour,Kelly M. Pennington,Scott E. Evans,Eva M. Carmona,Shahid Husain,Kenneth S. Knox,(unknown),Élie Azoulay,William Hope,(unknown),M. Hassan Murad,Andrew H. Limper,Chadi A. Hage	4
3	Biomarkers of cellular senescence in idiopathic pulmonary fibrosis 2023 ·Respiratory Research ·Zaira Aversa,Elizabeth J. Atkinson,Eva M. Carmona,Thomas A. White,(unknown),Sarah K. Jachim,Xu Zhang,Steven R. Cummings,Sergio E. Chiarella,Andrew H. Limper,Nathan K. LeBrasseur	21
4	Comparing the Utilization of Antifibrotic Medications Based on Income Level 2023 ·CHEST Journal ·Timothy Dempsey,Viengneesee Thao,(unknown),Lindsey R. Sangaralingham,Andrew H. Limper	0
5	Long-Term Pulmonary Function Trajectories After Allogeneic Bone Marrow Transplantation 2023 ·PubMed ·Hemang Yadav,Mehrdad Hefazi,William J. Hogan,Andrew H. Limper	0
6	Gene expression in lung epithelial cells following interaction with Pneumocystis carinii and its specific life forms yields insights into host gene responses to infection 2022 ·Microbiology and Immunology ·Theodore J. Kottom,Eva M. Carmona,Andrew H. Limper	5
7	Association of outpatient ACE inhibitors and angiotensin receptor blockers and outcomes of acute respiratory illness: a retrospective cohort study 2021 ·BMJ Open ·Molly M. Jeffery,Nathan W. Cummins,Timothy Dempsey,Andrew H. Limper,Nilay D. Shah,Fernanda Bellolio	6
8	Tissue-resident CD8 ⁺ T cells drive age-associated chronic lung sequelae after viral pneumonia 2020 ·Science Immunology ·Nick P. Goplen,Yue Wu,Young Min Son,Chaofan Li,Zheng Wang,In Su Cheon,Li Jiang,Bibo Zhu,Katayoun Ayasoufi,Eduardo N. Chini,Aaron J. Johnson,Robert Vassallo,Andrew H. Limper,Nu Zhang,Jie Sun	90
9	PD-1 ^hi CD8 ⁺ resident memory T cells balance immunity and fibrotic sequelae 2019 ·Science Immunology ·Zheng Wang,Shaohua Wang,Nick P. Goplen,Chaofan Li,In Su Cheon,Qigang Dai,Su Huang,Jinjun Shan,Chaoyu Ma,Zhenqing Ye,Min Xiang,Andrew H. Limper,(unknown),Jacob E. Kohlmeier,Mark H. Kaplan,Nu Zhang,Aaron J. Johnson,Robert Vassallo,Jie Sun	97
10	Knowledge Gaps and Research Priorities in Immune Checkpoint Inhibitor–related Pneumonitis. An Official American Thoracic Society Research Statement 2019 ·American Journal of Respiratory and Critical Care Medicine ·Catherine R. Sears,Tobias Peikert,Jennifer D. Possick,Jarushka Naidoo,Mizuki Nishino,Sandip Pravin Patel,Philippe Camus,Mina Gaga,Edward B. Garon,Michael K. Gould,Andrew H. Limper,(unknown),William D. Travis,M. Patricia Rivera	96
11	Distinct Cancer-Promoting Stromal Gene Expression Depending on Lung Function 2019 ·American Journal of Respiratory and Critical Care Medicine ·(unknown),Laìa Masvidal,Carl Murie,Margarita Bartish,Svetlana Avdulov,LeeAnn Higgins,Todd W. Markowski,Mark S. Peterson,Jonas Bergh,Ping Yang,Charlotte Rolny,Andrew H. Limper,Timothy J. Griffin,Peter B. Bitterman,Chris H. Wendt,Ola Larsson	18
12	Clinical Effectiveness of Antifibrotic Medications for Idiopathic Pulmonary Fibrosis 2019 ·American Journal of Respiratory and Critical Care Medicine ·Timothy Dempsey,Lindsey R. Sangaralingham,Xiaoxi Yao,Darshak Sanghavi,Nilay D. Shah,Andrew H. Limper	92
13	Microbiological Laboratory Testing in the Diagnosis of Fungal Infections in Pulmonary and Critical Care Practice. An Official American Thoracic Society Clinical Practice Guideline 2019 ·American Journal of Respiratory and Critical Care Medicine ·Chadi A. Hage,Eva M. Carmona,Oleg Epelbaum,Scott E. Evans,(unknown),Qusay Haydour,Kenneth S. Knox,Jay K. Kolls,M. Hassan Murad,Nancy L. Wengenack,Andrew H. Limper	116
14	Glycosphingolipids Mediate Pneumocystis Cell Wall β-Glucan Activation of the IL-23/IL-17 Axis in Human Dendritic Cells 2012 ·American Journal of Respiratory Cell and Molecular Biology ·Eva M. Carmona,Theodore J. Kottom,Deanne Hebrink,Teng Moua,(unknown),Richard E. Pagano,Andrew H. Limper	36
15	Genetic Variants Associated with the Risk of Chronic Obstructive Pulmonary Disease with and without Lung Cancer 2011 ·Cancer Prevention Research ·Mariza de Andrade,Yan Li,Randolph S. Marks,Claude Deschamps,Paul D. Scanlon,(unknown),Ruoxiang Jiang,Stephen J. Swensen,Zhifu Sun,Julie M. Cunningham,Jason A. Wampfler,Andrew H. Limper,David E. Midthun,Ping Yang	19
16	Temozolomide-Associated Organizing Pneumonitis 2007 ·Mayo Clinic Proceedings ·Fabien Maldonado,Andrew H. Limper,Kaiser G. Lim,Marie‐Christine Aubry	11
17	Temozolomide-Associated Organizing Pneumonitis 2007 ·Mayo Clinic Proceedings ·Fabien Maldonado,Andrew H. Limper,Kaiser G. Lim,Marie-Christine Aubry	12
18	Imatinib mesylate inhibits the profibrogenic activity of TGF-β and prevents bleomycin-mediated lung fibrosis 2004 ·Journal of Clinical Investigation ·Craig Daniels,Mark C. Wilkes,Maryanne Edens,(unknown),Stephen J. Murphy,Andrew H. Limper,Edward B. Leof	442
19	Acute Eosinophilic Pneumonia: Histopathologic Findings in Nine Patients 1997 ·American Journal of Respiratory and Critical Care Medicine ·Henry D. Tazelaar,(unknown),Thomas V. Colby,Jeffrey L. Myers,Andrew H. Limper	95
20	Immunohistochemical Localization of Transforming Growth Factor-Beta 1 in the Nonnecrotizing Granulomas of Pulmonary Sarcoidosis 1994 ·American Journal of Respiratory and Critical Care Medicine ·Andrew H. Limper,Thomas V. Colby,(unknown),(unknown),Patrick C. Roche,Richard A. DeRemee	73

About Andrew H. Limper

Andrew H. Limper is a scholar working on Infectious Diseases, Epidemiology and Pulmonary and Respiratory Medicine, having authored 290 papers that have together received 14.3k indexed citations. Recurring topics across this work include Pneumocystis jirovecii pneumonia detection and treatment (153 papers), Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis (74 papers) and Pneumonia and Respiratory Infections (62 papers). The work is most often cited by research in Infectious Diseases (4.4k citations), Epidemiology (6.4k citations) and Pulmonary and Respiratory Medicine (4.9k citations). Andrew H. Limper has collaborated with scholars based in United States, China and United Kingdom. Frequent co-authors include Charles F. Thomas, Joseph E. Standing, Thomas V. Colby, Theodore J. Kottom, Robert Vassallo, Eva M. Carmona, Steven H. Yale, Edward B. Leof, Jay H. Ryu and Craig Daniels. Their work appears in journals such as New England Journal of Medicine, Proceedings of the National Academy of Sciences and Journal of Biological Chemistry.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact